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Introduction {#sec1}
============

The majority of new human immunodeficiency virus-1 (HIV-1, referred to as HIV hereafter) infections worldwide occur through sexual mucosal transmission, of which young women are most vulnerable ([@bib40]; [@bib84]; [@bib119]). During sexual transmission, HIV gains entry at mucosal sites (vaginal, penile, and anal mucosae) through breaks in the mucosal epithelial barrier to infect a founder population of susceptible targets ([@bib3]; [@bib34], [@bib35]; [@bib103]). During the eclipse phase of infection, focal clusters of infected cells replicate sufficient virus in mucosal T cells and macrophages that then leads to viral spread to draining and distant lymphoid organs ([@bib34], [@bib35]; [@bib89]). Our current understanding of viral dissemination kinetics following vaginal HIV infection come from studies with SIV-infected macaques ([@bib71]), where locally infected cells in cervical vaginal tissues (CVTs) is followed by rapid dissemination into the draining lymph nodes (LNs), before spreading to distant lymphoid tissues and detection in blood ([@bib19]; [@bib35]; [@bib41]; [@bib66]). Similar viral dissemination kinetics were also observed after vaginal challenge of BLT humanized mice ([@bib19]) supporting the paradigm that HIV spread from the CVT to distant tissues is a stepwise progression of events that, once systemic dissemination is achieved, becomes difficult to eradicate with current drug regimens owing to the establishment of the latent reservoir ([@bib117], [@bib118]).

HIV reaches the genital-draining LN by two plausible mechanisms: (1) passive transport of infectious HIV particles released by infected CVT cells that enter the LNs via the lymphatics and (2) transport by infected or virus-carrying leukocytes via their natural trafficking into and within LNs, followed by their delivery to susceptible CD4+ T cells through cell-cell contact ([@bib16]; [@bib40]; [@bib49]; [@bib97]). Although these mechanisms are not mutually exclusive, we previously showed that blocking leukocyte trafficking in and out of tissues after vaginal or subcutaneous HIV challenge in BLT humanized mice led to significant inhibition or delay in viremia and tissue viral loads ([@bib19]; [@bib74]). Interfering with leukocyte recirculation in chronically infected animals did not impact viremia ([@bib74]), suggesting that HIV is actively carried into peripheral tissues and blood by migratory cells predominantly during the early stages of infection. More recently, we showed that enhanced migratory capacity of infected T cells, by disrupting Nef-mediated dysregulation of the actin cytoskeleton, accelerated systemic viral dissemination shortly after vaginal transmission, further implicating HIV-infected lymphocytes as motile vehicles for efficient viral spread ([@bib108]). Thus, HIV can hijack physiological immune surveillance, cellular trafficking and intercellular communication in order to evade immune recognition and reach large numbers of susceptible T cells in lymphoid organs ([@bib23]; [@bib76]).

Cervical dendritic cells (DCs) can promote systemic viral spread through capture of infectious HIV particles and their transport to the draining lymph nodes, where virus is spread to susceptible T cells via cell-cell contact, termed DC *trans*-infection ([@bib11]; [@bib27]; [@bib42]; [@bib104]; [@bib120]). Although the cellular aspects of cell-cell HIV transmission are well described, most studies were done exclusively using culture systems that do not consider the highly motile nature and cell-cell contact dynamics between DCs and T cells observed in the lymph node. Another outstanding question is how DCs, in the absence of productive infection, restrain motile T cells to promote stable DC:T cell conjugates to facilitate viral transfer. We and others have utilized 3D collagen model systems to better characterize the dynamic on-off kinetics between infected and uninfected cells and have described key aspects of cell-cell contact behaviors that impact viral dissemination kinetics and pathogenesis ([@bib63]; [@bib101]; [@bib108]). Herein, we addressed whether HIV-captured DCs retain their ability to exit the genital mucosae, enter the lymphatic vessels, and migrate toward LN-homing chemo-attractants and whether they can restrain motile T cells for long enough to permit viral transfer in the absence of cognate antigen recognition. We show that mature monocyte-derived DCs were highly efficient at capturing cell-free HIV particles which, over time, became condensed within compartments close to the uropodia of motile DCs. Consistent with previous studies, HIV particle capture was dependent on Siglec-1 and required actin cytoskeletal mobilization to compartmentalize virus for at least 24 h. HIV-captured DCs retain their ability to respond to tissue exit chemo-attractants CCL19/21 and S~1~P by facilitating entry into and within lymphatic vessels. Using our 3D collagen imaging model, we show that CD4 T cells engaged in prolonged contacts with HIV-captured DCs that were dependent on gp120:CD4 interactions and further strengthened through LFA-1:ICAM-1 binding. Stable DC:T cell contacts resulted in increased T cell infection, highlighting an unexpected mechanism by which surface-bound HIV particles on DCs can function as adhesive receptors to contact and restrain motile T cells to facilitate HIV spread.

Results {#sec2}
=======

Mature Dendritic Cells Readily Capture and Compartmentalize HIV into Clusters near the Uropodia {#sec2.1}
-----------------------------------------------------------------------------------------------

Mature DCs capture and transmit infectious HIV particles to susceptible T cells more efficiently than immature DCs, whereas the latter are more susceptible to HIV infection ([@bib105]). LPS-stimulated DCs upregulated HLA-DR, CD80/86, and CD83 and were more migratory compared with immature DCs in 3D collagen matrices ([Figure S2](#mmc1){ref-type="supplementary-material"}). To better characterize HIV capture dynamics by motile DCs, we generated a dual-fluorescent HIV reporter that incorporates both the Gag-iGFP gene and *nef*-IRES-dTomato cassette (Gag-iGFP/dTomato).The resulting viral particles are brightly labeled by incorporation of the Gag-iGFP fusion protein, whereas infected cells express high levels of dTomato, allowing us to discriminate between productively infected (GFP^+^dTomato^+^) and HIV-captured but uninfected (GFP^+^dTomato^neg^) DCs and T cells ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}). Cell surface CD4 downregulation was observed only in dTomato^+^ cells, confirming functional Nef expression ([Figure S1](#mmc1){ref-type="supplementary-material"}). Immature and LPS-stimulated MDDCs were incubated with virus for up to 28 h, and viral capture kinetics was evaluated by flow cytometry. As expected, mature DCs efficiently captured and retained HIV particles for up to 28 h, whereas immature DCs rapidly degraded HIV particles shortly after capture and only 2.6% of cells contained measurable HIV-iGFP after 28 h ([Figures 1](#fig1){ref-type="fig"}B and 1C). We did not observe infected, dTomato^+^ only DCs during this time course experiment ([Figure 1](#fig1){ref-type="fig"}B). Next, we sought to visualize viral capture dynamics by DCs within a 3D fibrillar space that allowed cells to migrate and retain morphological features observed at mucosal surfaces *in vivo*. Celltracker blue-labeled DCs were co-embedded with HIV-iGFP particles in a 3D collagen matrix and visualized for up to 24 h ([Figure 1](#fig1){ref-type="fig"}D and [Video S1](#mmc1){ref-type="supplementary-material"}). Although immature DCs remained immotile and weakly retained HIV clusters, mature DCs exhibited large dendritic extension, were migratory, and contained HIV particles. In the first hour, HIV particles were found dispersed throughout the cell, but over time, large viral clusters became visible near the trailing edge of migratory DCs, followed by distinct HIV compartmentalization by 5 h post-viral exposure ([Figures 1](#fig1){ref-type="fig"}D and 1E). This was confirmed by line profile analysis, showing that all DCs analyzed have compartmentalized virus by 24 h ([Figure 1](#fig1){ref-type="fig"}E). These studies confirm that mature DCs capture and retain HIV within clusters that seem to polarize toward the trailing edge, or uropodia, of motile DCs within a 3D environment.Figure 1HIV Capture Kinetics and Localization by Mature DCs in 3D Collagen(A) Schematic illustration of the HIV-iGFP/dTomato reporter vector. PR, protease cleavage site.(B) Immature or LPS-stimulated MDDCs were incubated with HIV-iGFP/dTomato for the indicated times and viral capture kinetics assessed by flow cytometry. Numbers indicate % of DCs that captured HIV-iGFP particles.(C) Time course analysis of HIV-iGFP capture by DC populations. Representative data from two (immature DC) and three (mature DC) independent experiments are shown. Mean ± SEM.(D) A time series micrograph of immature or LPS-stimulated DCs exposed to HIV-iGFP in collagen for the indicated times. Time stamp in min:sec represents elapsed time of the recordings and not the start of HIV incubation. Right panels: 3D surface rendering of DCs and HIV particles, with XY, YZ, and XZ views that illustrate viral particle distribution.(E) Representative line profile analysis of GFP fluorescence intensity in HIV-captured DC, from the leading to the trailing edge of each cell. Representative "HIV capture" and "HIV compartmentalization" line profiles are shown. HIV compartmentalization was defined as \>70% of total GFP fluorescence that is confined within the training edge of polarized DCs. Relative proportion of HIV found compartmentalized over time is shown. Data from two independent experiments are shown (n = 303 total cells).

Video S1. HIV Capture Dynamics by Motile DCs in Collagen, Related to Figure 1CMAC-labeled MDDCs (blue) were either left alone or exposed to HIV-iGFP (green) and embedded into collagen gels for live-cell imaging. Each individual frame is a maximum intensity projection of 12 z stacks spaced 4 μm apart (total thickness of 44 μm). Scale bar, 20 μm. Time is shown in min:sec elapsed of the movie recording.4

HIV Clusters within CD81-Rich Compartments near the Uropodia of Motile DCs {#sec2.2}
--------------------------------------------------------------------------

To better define the HIV-containing compartment, HIV-containing DCs (1 h virus pulse) were labeled with fluorophore-conjugated antibodies recognizing the uropodial marker P-selectin glycoproptein-1 (PSGL-1) or CD81 prior to collagen embedding for live-cell imaging. We observed strong co-localization between HIV clusters and both PSGL-1 and CD81, but not with dextran-containing endosomes, confirming that virus-containing compartments (VCCs) are distinct from endosomes ([Figures 2](#fig2){ref-type="fig"}A and 2B). Ultrastructural analysis using electron microscopy of HIV-captured DCs in collagen confirmed that mature viral particles were contained close to the cell surface membrane within invaginated pockets ([Figures 2](#fig2){ref-type="fig"}E and [S3](#mmc1){ref-type="supplementary-material"}). These data confirm that the observed GFP + clusters in DCs were indeed mature HIV particles and not endocytosed free Gag-iGFP proteins. We observed some DCs that had more than one irregularly shaped VCCs near the uropodia containing mostly mature HIV, and no viral budding events in this compartment was observed in our analysis. [@bib70] showed that dynamin-2, a regulator of actin polymerization, helped facilitate the formation of HIV-containing compartments within DCs. Indeed, pre-treatment of DCs with Dynasore, a reversible inhibitor of dynamin, did not interfere with HIV capture but resulted in a complete loss of viral cluster polarization and migration ([Figure 2](#fig2){ref-type="fig"}C and [Video S2](#mmc1){ref-type="supplementary-material"}). Phalloidin staining of formalin-fixed, Dynasore-treated DCs in collagen, which preserved the dendritic features of motile DCs, confirmed lower F-actin content and increased endocytosis of HIV particles ([Figure 2](#fig2){ref-type="fig"}D). When Dynasore was removed from the cell suspension by media wash after 2 h of drug treatment, DC motility and virus compartmentalization was restored, supporting the notion that actin networks are crucial for VCC maintenance in motile DCs.Figure 2HIV Capture Kinetics and Localization by Mature DCs in 3D Collagen(A) Micrograph of mature DCs stained for PSGL-1, CD81 or pulsed with fluorescently labeled dextran after pulsing with HIV particles for 1 h. DCs were embedded into collagen matrix for live-cell imaging.(B) Representative life profile analysis of GFP and PSGL-1, dextran or CD81 fluorescent intensity in a polarized, HIV-captured DC (n = 33 total cells). Fluorescence intensity is expressed as arbitrary units (a.u.).(C) Time-lapse micrograph of HIV-captured DCs that were either left alone or treated with Dynasore and prepared for live-cell imaging in collagen matrix. HIV-iGFP signal intensity is depicted using LUT union Jack analysis. Dynasore "wash out" condition involved washing DCs with media after 2 h of drug treatment.(D) HIV-captured DCs were either left alone or treated with Dynasore, then embedded in collagen and fixed with PFA *in situ* at 37°C. DCs were stained with phalloidin-Texas red. Representative micrograph of HIV-captured DCs are shown.(E) Transmission electron micrograph of a polarized DC in collagen matrix. HIV particles are observed within surface-accessible compartments (yellow arrowheads in enlarged insets). The leading and training edges are indicated, based on the location of the nucleus (N).

Video S2. Actin Polymerization Maintains VCCs Near the DC Uropodia, Related to Figure 2Labeled MDDCs were exposed to HIV-iGFP, then treated with the inhibitor Dynasore (+Dynasore) before embedding into collagen gels for live-cell imaging. Treated HIV-captured DCs were washed prior to imaging (washed out). Each individual frame is a maximum intensity projection of 12 z stacks spaced 4 μm apart (total thickness of 44 μm). HIV-iGFP signal intensity is depicted by LUT union Jack analysis. Time is shown in min:sec elapsed of the movie recording.5

Siglec-1 Facilitates HIV Compartmentalization in Motile DCs {#sec2.3}
-----------------------------------------------------------

Previous studies ([@bib124]; [@bib45], [@bib47], [@bib46]; [@bib81]) showed that Siglec-1 (CD169) was largely responsible for HIV capture by DCs in a gp120-independent manner. Indeed, wild-type and HIV-iGag*ΔEnv* were captured with equal efficiencies and compartmentalized by DCs near the uropodia ([Figure 3](#fig3){ref-type="fig"}A). As Siglec-1 is upregulated in mature MDDCs ([Figure 3](#fig3){ref-type="fig"}B), we further confirmed that Siglec-1 was the predominant receptor that facilitated HIV capture, as blockade with anti-Siglec-1 antibody (at a titrated dose that yielded ∼90% receptor blockade) led to near-complete reduction of both wild-type and HIV*ΔEnv* capture and retention ([Figures 3](#fig3){ref-type="fig"}C and 3D). This was also confirmed by immunostaining in collagen gels, where wild-type and HIV*ΔEnv* both co-localized with Siglec-1 at the uropodia of migrating DCs ([Figures 3](#fig3){ref-type="fig"}E and 3F). Conversely, blockade with anti-DC-SIGN did not lead to significant reduction in HIV capture ([Figure S4](#mmc1){ref-type="supplementary-material"}B), although DCs did express the receptor. DC-SIGN expression did not co-localize with viral clusters near the uropodia of polarized DCs in collagen ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C), indicating that DC-SIGN played a minimal role in viral capture in our model. Notably, Siglec-1 expression in control DCs were not localized exclusively in the uropodia, suggesting that HIV-binding caused HIV:Siglec-1 clusters to relocate toward the uropodia.Figure 3Siglec-1 Mediates HIV Capture and Uropodial Compartmentalization in Motile DCs(A) Micrograph of mature DCs pulsed with either wild-type or *ΔEnv* HIV-iGFP, washed, and embedded in collagen for live-cell imaging. Time stamp: min:sec.(B) Expression of cell surface Siglec-1 on mature DCs.(C) DCs were treated with either isotype or anti-Siglec-1 antibody prior to exposure to wild-type or *ΔEnv*HIV-iGFP. Numbers indicate % of DCs that captured HIV particles.(D) Percent HIV capture by DCs. Data was normalized to isotype antibody-treated cells. Mean ± SEM are shown. Representative data from four independent experiments are shown. n.s., not significant; ∗∗∗p \< 0.001. Unpaired Student\'s t test.(E) Micrograph of HIV-captured DCs stained for Siglec-1 in collagen.(F) Representative line profile analysis of GFP and Siglec-1 fluorescent intensity in a polarized, HIV-captured DC shown in (E). Representative data from three independent experiments are shown.

HIV-Captured DCs Retain Migration toward Lymph Node Homing Chemokines {#sec2.4}
---------------------------------------------------------------------

Mucosal DCs capture antigens and actively migrate to the draining lymph node via the afferent lymphatics ([@bib65]; [@bib82]; [@bib86]; [@bib88]). Although HIV-captured DCs appear to retain their baseline motility, albeit at a lower velocity ([Figure S1](#mmc1){ref-type="supplementary-material"}), we addressed whether virus capture altered their migration toward tissue exit chemo-attractants CCL19/21 and S~1~P. No changes in their respective receptors CCR7 or S~1~PR1 on DCs before and after HIV exposure was observed, and comparable chemotactic responses toward CCL19/21 and S~1~P gradients were noted between the two DC populations ([Figures 4](#fig4){ref-type="fig"}A and 4B). Chemotactic responses of HIV-captured DCs were significantly reduced by anti-CCR7 antibody and FTY720 treatment that blocks CCR7- and S~1~PR1-mediated chemotaxis, respectively. We next addressed whether HIV-captured DCs were able to enter and migrate within lymphatic vessels, a critical step for active dissemination into the lymph node. We utilized an *ex vivo* explant model of the murine ear dermis, taking advantage of the fact that human immune cells responded robustly to murine CCL19/21 ([@bib19]). Lymphatic vessels from mouse explants were labeled using anti-LYVE-1 antibody, then a 1:1 mixture of control and HIV-captured DCs were overlaid for 15 min to allow for cells to enter the dermal layers of the skin for microscopy analysis ([Figure 4](#fig4){ref-type="fig"}C). We found equal proportions of control and HIV^+^ DCs within lymphatic vessels and dermal interstitium, demonstrating that DCs suffered no defect in lymphatic entry after HIV capture ([Figure 4](#fig4){ref-type="fig"}D). Pre-treatment of DCs with anti-CCR7 antibody and FTY720 (an S~1~PR1 antagonist) resulted in a shift in DC proportions from the lymphatic vessels to the interstitial space, compared with vehicle-treated cells ([Figure 4](#fig4){ref-type="fig"}E). Notably, CCR7/S~1~PR1 dual blockade led to non-linear motility toward the nearest lymphatic vessel and a more tortuous DC migration pattern, showing loss of directionality ([Figures 4](#fig4){ref-type="fig"}F and 4G). Together, HIV capture and compartmentalization in DCs did not abrogate their chemotactic responses toward tissue exit signals, and both CCR7 and S~1~PR1 enabled DC entry and intraluminal crawling within lymphatic vessels ([Figure 4](#fig4){ref-type="fig"}H and [Video S3](#mmc1){ref-type="supplementary-material"}).Figure 4HIV-Captured DCs Display Robust Migration and Lymphatic Vessel Entry(A) Cell surface expression of CCR7 and S~1~PR1 on control or HIV-captured DCs.(B) Transwell migration analysis of control or HIV-captured DCs in response to media, CCL19/21, or S~1~P. In some conditions, DCs were pre-treated with anti-CCR7 blocking antibody or FTY720-P before subjecting them to the migration assay. Migration index was calculated as fold increase in the number of DCs that responded to chemokine compared with media alone. Mean chemotactic responses +/− SEM toward CCL19/21 and S~1~P from three and two independent experiments, respectively, are presented. ∗p \< 0.05, Mann-Whitney U test.(C) Experimental design of the *ex vivo* skin crawl-in assay. A mixture of control and HIV-captured DCs (1:1) were pre-treated either with vehicle or with both anti-CCR7 antibody and FTY720-P, washed, and overlaid on dermal tissue. Cells that did not enter the tissue were washed and prepared for live-cell imaging. Right panel: representative micrograph of control and HIV-captured DC distributions in the presence or absence of chemokine receptor blockade.(D) Relative distribution of control or HIV-captured DCs within the visualized dermal lymphatics or interstitium compartment. Mean values from four independent experiments +/− SEM are shown. n.s., not significant, chi-square test.(E) Relative distribution of HIV-captured DCs before and after chemokine receptor blockade with the visualized dermal lymphatics or interstitium. ∗p \< 0.05, chi-square test.(F) Confinement ratio within the dermal skin layer before or after receptor blockade. Unpaired Student\'s t test was performed. n.s., not significant. ^∗∗∗∗^p \< 0.001. Confinement ratio is defined as the ratio of the displacement of a cell to the total length of the path the cell has traveled. Data from four independent experiments are shown. Mean ± SEM are shown.(G) Total displacement of DCs within the dermal skin layer before or after receptor blockade. Mann-Whitney U test was performed. n.s., not significant. ^∗∗∗∗^p \< 0.001. Data from four independent experiments are shown. Mean ± SEM are shown.(H) Time-lapse micrograph of an HIV-captured DC undergoing intraluminal crawling. Scale bar, 20μm.

Video S3. HIV-Captured DCs Can Enter Lymphatics and Perform Intraluminal Crawling, Related to Figure 4CMAC-labeled MDDCs (blue) were either left alone or exposed to HIV-iGFP (green) and overlaid onto the mouse dermal layer. Lymphatic vessels were visualized using anti-LYVE-1 antibody (red), and DCs migrating within the dermal tissues were visualized my microscopy. Comparison of DC migration behaviors with or without anti-CCR7/FTY720-P treatment is shown. Bottom left panel: Intraluminal crawling of HIV-captured DCs with lymphatic vessels. Each individual frame is a maximum intensity projection of 12 z stacks spaced 4 μm apart (total thickness of 44 μm). Time is shown in min:sec elapsed of the movie recording.6

Prolonged DC:T Cell Engagement Is Facilitated through gp120:CD4 Interaction {#sec2.5}
---------------------------------------------------------------------------

Mature DCs migrate into and within the T cell zone of the lymph node to maximize access to naive T cells ([@bib69]; [@bib73]). Virological synapse (VS) formation between HIV-infected and uninfected cells are well described and serve as a direct conduit for efficient HIV spread to susceptible T cells ([@bib49]; [@bib51]). We next sought to visually characterize the cellular dynamics during DC:T cell *trans*-infection within a fibrillar 3D environment that allows cells to migrate, locate, and engage other cells in a manner that are reflective of interactions observed in the LN. Activated CD4^+^ T cells were co-cultured with either HIV-captured DCs or cell-free HIV particles in collagen matrices for 4 h, after which T cells were isolated and incubated in fresh media for an additional 48 h to measure productive, dTomato expression ([Figure 5](#fig5){ref-type="fig"}A). The presence of DCs significantly increased T cell infection compared with cell-free virus alone, and raltegravir pre-treatment completely inhibited infection in both experimental conditions. Next, we addressed how physiological DC:T cell contact dynamics were impacted upon HIV exposure using live-cell microscopy. As expected, DC:T cell contacts in the absence of infection remained brief, with mean durations lasting under 5 min, whereas extended DC:T cell contacts (mean duration of ∼17 min) were observed in the presence of HIV particles ([Figures 5](#fig5){ref-type="fig"}B and 5C and [Video S4](#mmc7){ref-type="supplementary-material"}). When DC:T cell contact durations were further characterized as brief (\<5 min), scanning (5--17 min), or stable (\>17 min), we noted that more than 70% of all DC:T cell conjugates were either scanning or stable contacts in the presence of virus ([Figure 5](#fig5){ref-type="fig"}D), indicating a substantial increase in DC:T cell dwell times. Surprisingly, stable DC:T cell contacts were completely abrogated in the presence of HIV-iGag*ΔEnv*, suggesting that gp120:CD4 interactions facilitate durable DC:T cell contacts. Similar reductions in DC:T cell contact duration was observed after CD4 antibody blockade ([Figures 5](#fig5){ref-type="fig"}C and 5D). Since HIV-captured DCs were not productively infected and did not express *de novo* gp120 on the cell surface, we interpreted these data as surface-accessible Siglec-1:HIV complexes functioning as adhesive molecules to retain motile T cells as they scan the DC surface. Indeed, T cells contacting control DCs or Env-deficient virus-containing DCs did not decelerate during contacts, whereas a substantial reduction in scanning speeds was observed in T cells contacting HIV-captured DCs ([Figures 5](#fig5){ref-type="fig"}E--5G). These data suggest that surface-accessible HIV particles may function as adhesive molecules to "slow" T cell migration, prolonging DC:T cell contact times to enhance cell-cell HIV spread.Figure 5HIV-Captured DCs Engage in Prolonged Contacts with T Cells in a gp120:CD4-Dependent Manner(A) Control or HIV-captured DCs were co-cultured with T cells and embedded into a collagen matrix for 4 h. T cells were extracted after collagenase treatment and incubated for an additional 48 h to measure productive infection. Normalized fold increase in T cell infection in the indicated conditions are shown. Data are from three independent experiments. Mean ± SEM are shown. Ral, raltegravir. ∗∗∗p \< 0.01, Unpaired Student\'s t test.(B) Time-lapse micrographs of DC:T cell contacts that are defined as brief or prolonged interactions. Time stamp are in min:sec of the movie recordings.(C) DC:T cell contact duration in the presence of wild-type or HIV-iGFP*ΔEnv*. Red lines indicate median values. αCD4, anti-CD4 antibody. ∗∗∗∗p \< 0.001, Mann-Whitney U test. Data from ten independent experiments are shown (n = 1,172 total DC:T cell contact events).(D) Percent distribution of DC:T cell contact times defined as brief (\>7 min; black), prolonged (7--17 min; blue), or stable (\>17 min; red) are shown.(E) Representative of instantaneous speeds of a T cell during a brief, prolonged, or stable contact with a DC is shown. Red shaded area represents a DC-T cell contact event. Data from two independent experiments are shown (n = 3 of total DC:T cell contact events).(F) Mean T cell velocity during brief, prolonged, or stable contacts with HIV-captured DCs. Red lines indicate median values. Data from three independent experiments are shown (n = 75 total cells). ∗∗∗∗p \< 0.001, Mann-Whitney U test.(G) Mean T cell velocity during contact with control, wild-type HIV, or HIV-iGag*ΔEnv-*pulsed DCs. Mean velocity was defined as the average speeds of a single T cell track contacting a DC. Red lines indicate median values. Data from three independent experiments are shown (n = 171 total cells). ns, not significant. ∗∗∗∗p \< 0.001, Mann-Whitney U test.

Video S4. Reduction in T Cell Speeds While Contacting HIV-Captured, But Not Control DCs, Related to Figure 5CMTMR-labeled DCs (red) were either left alone or exposed to HIV-iGFP (green) prior to co-culture with autologous CD4 T cells (blue) for live-cell imaging in collagen chambers. Each individual frame is a maximum intensity projection of 12 z stacks spaced 4 μm apart (total thickness of 44 μm). Scale bar, 10 μm. Time is shown in min:sec elapsed of the movie recording.7

gp120:CD4 Binding Induces Signaling that Further Stabilizes DC:T Cell Interactions {#sec2.6}
----------------------------------------------------------------------------------

We postulated that repeated gp120:CD4 interactions during T cell scanning of the DC surface may invoke signals that promote stable DC:T cell conjugates. Previous studies have demonstrated that gp120:CD4 engagement induces phosphorylation of Lck, TCRζ chain, and AKT and induces T cell stop ([@bib39]; [@bib112], [@bib109]). Since LFA-1:ICAM-1 adhesive contacts are also an essential facilitator of DC *trans-*infection ([@bib39]; [@bib114]), we tested whether Siglec-bound HIV can regulate LFA-1 activation in scanning T cells. Using a monoclonal antibody that binds to high affinity confirmation LFA-1 (clone 24) ([@bib60]), a measurable increase in high affinity LFA-1 was observed in T cells after co-culture with wild-type HIV-pulsed DCs, but not with control or HIV-iGag*ΔEnv*-pulsed DCs, suggesting that gp120-mediated modulation of T cell migration was at least partially dependent on LFA-1 activation ([Figure 6](#fig6){ref-type="fig"}A). Blocking LFA-1:ICAM-1 interactions resulted in a substantial reduction in stable DC:T cell contacts and lower T cell infection, supporting their role in cell-cell stabilization and viral transmission ([Figures 6](#fig6){ref-type="fig"}B--6D). To further identify signaling networks activated by gp120:CD4 interactions, T cells were co-cultured with DCs pulsed with either wild-type or HIV-iGag*ΔEnv*, harvested after 15 min and analyzed for signaling networks using a custom human peptide kinome array ([@bib79]). Ingenuity pathway analysis (IPA) identified upregulation of the PI3K pathway, calcium signaling, and ERK/MAPK pathways in T cells, among others, during contacts with wild-type, but not HIV-iGag*ΔEnv*-captured DCs ([Figure 6](#fig6){ref-type="fig"}E and [Table S1](#mmc1){ref-type="supplementary-material"}). InnateDB analysis also predicted upregulation of "TCR signaling," "MAPK pathways," and "Focal adhesions" ([Table S2](#mmc3){ref-type="supplementary-material"}), identifying signaling pathways that are initiated through Env:CD4 engagement.Figure 6LFA-1:ICAM-1 Binding Stabilizes Stable DC:T Cell Contacts and Facilitates Viral Transmission(A) Flow cytometry analysis of high-affinity LFA-1 expression (mAb clone 24) on T cells after co-culture with HIV-captured DCs. Data are normalized to no virus DC:T cell controls. Data from two healthy donors. Mean ± SEM are shown. ∗∗p \< 0.01, Unpaired Student\'s t test.(B) DC:T cell contact duration in the presence or absence of LFA-1:ICAM-1 interactions. ICAM-1, anti-ICAM-1 antibody; αLFA-1, anti-LFA-1 antibody. Red lines indicate median values. ∗∗p \< 0.01, ∗∗∗p \< 0.001, Mann-Whitney U test. Data from eight independent experiments are shown (n = 957 total DC:T cell contact events).(C) Percent distribution of DC:T cell contact times defined as brief (\>7 min; black), prolonged (7--17 min; blue), or stable (\>17 min; red) from data in (B) are shown.(D) Percent normalized T cell infection with the indicated antibody blockade. Data are from two independent experiments. Mean ± SEM are shown. n.s., not significant. ∗∗p \< 0.01, Unpaired Student\'s t test.(E) IPA identified biological pathways that were significantly (p \< 0.01) upregulated (*Z* score \> 1) in T cells co-cultured with wild-type HIV-pulsed DCs (T cells co-cultured with HIV-iGag*ΔEnv-*pulsed DCs set as background controls). The p value (red line), calculated with the Fischer\'s exact test, reflects the likelihood that the association between a set of activated kinases and a biological function is significant (p value ≤ 0.05).

Discussion {#sec3}
==========

During vaginal transmission, HIV establishes a focal infection within the CVT, which disseminates to draining and distant lymphoid organs prior to viral detection in blood. In order for HIV to establish a persistent infection, it needs to replicate quickly and find new target cells in the face of increasing adaptive immune pressure. It is now well documented that HIV takes advantage of the physiological trafficking properties of immune cells to gain access to large numbers of target T cells and that these mechanisms are particularly important during the early stages of transmission ([@bib19]; [@bib23]; [@bib75]; [@bib80]; [@bib108]). DCs can enhance viral spread in cultures ([@bib11]), but insights into cellular dynamics that orchestrate DC-to-T cell viral dissemination using experimental models that allow cells to migrate, locate, and engage each other are still lacking. The main question we addressed in this study is how HIV-captured DCs, which do not express *de novo* Env on the cell surface, regulate T cell behaviors in the absence of cognate antigen recognition. Herein, we have mapped key mechanisms of how migratory DCs capture, transport, and transmit infectious HIV to susceptible T cells and demonstrate that surface accessible Siglec:HIV clusters act as adhesive/signaling receptors to form a crucial contact point with scanning T cells. This in turn leads to gp120-mediated activation of LFA-1 and signal transduction that induces T cell stop and activation to promote high viral spread. Thus, we describe a mechanism by which a relatively small number of HIV-captured DCs, in the absence of infection, can ignite exponential T cell infection using a previously unknown mechanism of restraining motile T cells to maximize viral spread efficiency.

DCs act as tissue sentinels throughout the body, including the female genital tract (FGT) ([@bib62]; [@bib93]). The presence of microbial products and inflammatory stimuli leads to their maturation and upregulation of chemokine receptors that help direct their migration into secondary lymphoid organs, where a single DC will interact with up to 5,000 T cells per hour ([@bib6]; [@bib72]). Upon cognate antigen recognition, prolonged DC:T cell interactions dictate the magnitude of T cell differentiation, effector function, and memory responses ([@bib38]; [@bib69]). Although migratory DCs are less susceptible to productive HIV infection due to high expression of the restriction factor SAMHDI ([@bib57]), their ability to capture ([@bib5]) and transmit viral particles to T cells at the site of cell-cell contact, known as *trans-*infection, has implications on their ability to drive systemic dissemination after mucosal viral exposure ([@bib12]; [@bib44]; [@bib67]; [@bib122]). We previously showed that blocking leukocyte trafficking with the S~1~PR1 antagonist FTY720 or pertussis toxin, which inhibits G-protein-coupled receptors, substantially limited viral spread to peripheral tissue sites after vaginal HIV challenge of humanized mice ([@bib19]). To further extend these observations, we focused on the role of migratory DCs in this process and show that HIV-captured DCs retain their ability to migrate toward lymph node-homing chemo-attractants S~1~P and CCL19/21 and that their cognate receptor expression remains unchanged upon virus capture. Since murine S~1~P and CCL19/21 were functional on human cells, we took advantage of an *in situ* skin crawl-in assay to demonstrate that HIV-captured DCs displayed directional, haptotactic guidance toward the lymphatic vessel, followed by entry and intraluminal crawling under the influence of endogenous chemokine gradients. S~1~PR1/CCR7 dual blockade resulted in reduced DC accumulation near lymphatic vessels and displayed a more tenuous migratory path, indicating loss of directionality. These observations are supported by the role of CCR7 and S~1~PR1 in leukocyte egress from peripheral tissues into afferent lymphatics and LNs at homeostasis ([@bib9]; [@bib17]; [@bib18]; [@bib25]; [@bib30]; [@bib43]; [@bib58], [@bib59]; [@bib92]; [@bib102]; [@bib115]) and during inflammation ([@bib10]). Following lymphatic entry, DCs crawl on endothelial cells in the direction of lymph flow, but they get passively transported with the lymph once they reach collecting lymphatics ([@bib28]; [@bib102]). Notably, FTY720 treatment was more effective in suppressing viremia compared with CCR7 blockade after vaginal HIV exposure in humanized mice, suggesting that S~1~PR1 may play a dominant role in regulating DC egress. However, we cannot completely rule out the possibility that the CCR7 pathway might contribute to egress of other infected or HIV-containing cell types into peripheral tissues.

Siglec-1 is expressed in cervical CD14^+^CD11c^+^HLA-DR^+^ DCs and MDDCs and has been implicated in HIV capture and retention that is dependent on ganglioside GM3 binding and not HIV gp120 ([@bib14]; [@bib33]; [@bib45], [@bib47], [@bib46]; [@bib81]). This was confirmed in our study, as dense clusters of wild-type and Env-deficient HIV both co-localized with Siglec-1 near the DC uropodia. Ultrastructural analysis by TEM confirmed the presence of mature HIV particles within surface-accessible virus containing compartments (VCCs) and membrane invaginations near the rear end of polarized DCs. The observed HIV clusters also co-localized with CD81^+^ but were distinct from endosomes, consistent with previous characterizations of these non-lysosomal compartments in mature DCs ([@bib33]). It is likely that endocytosed HIV particles are rapidly degraded by phagolysosomes for antigen presentation, whereas those that are contained within Siglec-1^+^CD81^+^ compartments remain intact for up to 24 h, based on high HIV-GFP retention in our studies. Retained HIV particles can then access target CD4+ T cells through DC:T cell interactions in a way that is analogous to the capture of ganglioside-rich exosomes by mDCs and amplification of the immune response without antigen reprocessing ([@bib46]; [@bib78]). Subcapsular sinus (SCS) macrophages also express Siglec-1 (CD169) ([@bib2]; [@bib22]; [@bib32]; [@bib36]; [@bib53]; [@bib94]; [@bib106]) that play a vital role in pathogen capture and transport to DCs or the B cell follicles ([@bib32]; [@bib83]; [@bib113]). HIV and MLV (murine leukemia virus) have been shown to exploit SCS macrophages to access target CD4 T cells and B cells, respectively, and facilitate efficient viral spread *in vivo* ([@bib96]). In our study, Siglec-1 was rarely found near the uropodia in control DCs, whereas dense HIV:Siglec-1 clusters localized near the trailing edge shortly after HIV exposure. How HIV:Siglec-1 relocates near the uropodia is not clear, as Siglec-1 lacks tyrosine-based signaling motifs and the cytoplasmic tail is poorly conserved compared with others in the Siglec family ([@bib14]). However, the uropodia of migrating cells is a specialized platform for organelles, adhesion receptors, and key regulators of the actin polymerization machinery, suggesting that HIV:Siglec-1 clusters may be actively transported to the uropodia rather than passive accumulation. The trailing edge is also enriched with tetraspanin-containing microdomains that are crucial for the formation of VCCs ([@bib4]; [@bib100]). Interestingly, the uropodia of polarized T cells has been shown as the preferred site for membrane-associated Gag accumulation and VS formation ([@bib37]). Together, Siglec-1-mediated HIV capture and retention occur highly localized within the uropodia of migrating DCs, but within compartments that are accessible by T cells during DC:T cell interactions.

Two-photon microscopy analyses have revealed that naive T cells crawl along the surface of the FRC network in an apparently random manner and continually scan dendritic cells that are also situated on the same FRC networks, in search for cognate antigen ([@bib69]; [@bib73]). These studies have forced us to re-evaluate the interplay between cell motility, cell-cell contact dynamics, and *trans-*infection mechanisms, where dynamic DC:T cell interactions occur continuously. We performed live-cell imaging studies in collagen matrices to visually characterize how HIV-containing DCs alter the speed and duration of T cell scanning behaviors in a fibrillar 3D setting that better reflect their physiological interactions *in vivo*. High T cell infection rates were observed in the presence of DCs in collagen compared with free-virus alone, and this corresponded with a high proportion of stable DC:T cell contacts. Interestingly, we observed that stable DC:T cell conjugates were abrogated in the presence of Env-deficient HIV, or after CD4 antibody blockade, despite similar viral capture kinetics and localization to wild-type HIV. These data seemed to suggest that the presence of virus-containing invaginations modulated T cell scanning and migration and that this involved Env:CD4 interactions. Elegant ultrastructural analysis of the DC:T cell conjugate site has revealed T cell-derived filopodial protrusions that penetrate into the virion-rich folds of dendritic cells and attachment of viral particles along these actin-rich extensions ([@bib24]). Addition of blocking antibodies against gp120 resulted in retention of virions by dendritic cells, whereas CD4 antibody blockade prevented DC-to-T cell viral transmission. Together, these data illustrate a scenario where actively scanning T cells probe the DC surface with CD4-rich filopodial protrusions, which upon contact with HIV clusters embedded within membrane invaginations, leads to generation of signals that culminate in T cell arrest and VS formation in a gp120:CD4-dependent manner. Our observations that T cells appear either arrested or display low motility when contacting HIV-captured DCs, but not Env-deficient or control DCs, are in line with this model. Soluble and virion-associated gp120 can induce Ca^2+^ flux downstream of the chemokine receptors ([@bib68]; [@bib116]), and calcium signaling mediates T cell arrest upon cognate antigen recognition ([@bib8], [@bib7]). Whether calcium signaling is required for DC:T cell conjugate formation is unclear, since gp120 molecules embedded into planar lipid bilayers arrested T cells without detectible calcium release ([@bib109]). Other surface molecules can play a role in stabilizing the VS, as CD81 tetraspanin ([@bib31]), GM1 ganglioside ([@bib52]), and integrins ([@bib49], [@bib50]) have all been shown to accumulate at the site of cell-cell contact. Of particular importance are LFA-1:ICAM-1 adhesive interactions that facilitate VS formation ([@bib49]; [@bib50]; [@bib90]; [@bib110];[@bib112]) and cell-cell transmission ([@bib21]; [@bib50]; [@bib91]). Blocking LFA1/ICAM-1 binding abrogated prolonged DC:T cell contacts in collagen and reduced T cell infection. Importantly, we found that gp120:CD4 binding was required for activation of the high-affinity conformation of LFA-1 in T cells during co-cultures with HIV^+^ DCs, suggesting that HIV:CD4 binding represents an initial, critical step in facilitating prolonged DC:T cell contacts. Our data are consistent with previous studies where HIV gp120 triggered LFA-1 activation in resting CD4 T cells in a CD4-dependent manner ([@bib39]). Additionally, LFA-1 activation can also function beyond their adhesive properties to promote VS formation, as T cell polarization and MTOC reorganization toward the cell-cell contact site upon LFA-1 ligation has been reported ([@bib98]). Thus, our data describe a model where surface accessible HIV on DCs modulates T cell scanning behaviors by activating a gp120-dependent signaling cascade that favors stable DC:T cell contacts and viral transmission. It is unlikely that DC:T cell conjugates observed in our studies are the result of cognate antigen recognition, since T cells were isolated from healthy donors and the number of HIV-specific T cells are expected to be low. However, given that HIV-specific T cells are preferentially infected during acute infection ([@bib20]; [@bib64]), an intriguing question is whether antigen recognition further facilitates DC:T contacts that can simultaneously prime and transmit HIV particles to T cells, and is a focus of our ongoing studies.

HIV Env induces calcium flux, MEK/ERK activation, Lck phosphorylation, and partial ZAP-70 activation, among others, in CD4 T cells, but their role in viral entry or infection has been debated ([@bib13]; [@bib29]; [@bib39]; [@bib54]; [@bib68]; [@bib87]; [@bib112], [@bib109]). Recent studies by Lens et al. showed that Env:CD4 clustering at the site of T cell-T cell contact initiated signaling downstream of the T cell receptor in infected cells, leading to enhanced cell-cell HIV transmission ([@bib61]). In their study, robust signaling in target T cells were also observed, suggesting that *de novo* Env expression on infected T cells delivered activation signals during cell-cell contacts. Here, we addressed whether surface-bound HIV clusters induce similar T cell signaling pathways that modulate migratory behaviors in a way that favors viral spread. Our kinome array and IPA analysis confirmed activation of calcium signaling, TCR signaling, and ERK/MAPK pathways, among others, through Env:CD4 binding, which can collectively modulate T cell migration behaviors. Tec family of tyrosine kinases (*Z* score 2.1, p value 3.4x10^−6^) plays an indispensable role in T cell maturation, activation, and differentiation ([@bib1]; [@bib95]), where Itk phosphorylation downstream of the T cell receptor regulates Ca^2+^ mobilization, actin mobilization, and cytoskeletal reorganization. Previous studies have demonstrated that Itk is phosphorylated in T cells shortly after contact with gp120- and ICAM-1-embedded lipid bilayers ([@bib109]) and that Itk deficiency disrupts F-actin assembly and reduces intracellular p24 levels upon HIV infection ([@bib26]), suggesting that this pathway may regulate both T cell motility and virus transcription. Similarly, activation of the PI3K pathway (*Z* score 2.1, p value 1.3x10^−5^) through gp120:CD4 interactions may regulate T cell migration behaviors and help promote HIV infection post-viral entry ([@bib26]; [@bib77]). Finally, the canonical MAPK/ERK pathway (*Z* score 1.9, p value 1.1x10^−9^) regulates cell adherence, metabolism, and cell proliferation, and inhibiting ERK signaling is known to restrain ECM-induced cell motility ([@bib15]; [@bib55]; [@bib56]). Earlier work showed that ERK activation regulated HIV infectivity and was required for efficient organization of the reverse transcription complex ([@bib48]; [@bib121]). Activation of the Th17 signaling pathway may increase virus infection, as Th17-lineage CCR6^+^ CD4^+^ T cells are preferentially infected early during infection ([@bib85]; [@bib99]). Together, kinome analyses suggest that DC-bound HIV can activate signaling pathways that regulate both T cell motility and viral susceptibility. Signaling activation by surface-bound HIV is not surprising, given that as little as two HIV particles were sufficient to stimulate calcium influx in primary T cells ([@bib68]). Although there are a relatively low number of Env per virion (∼14 trimers) ([@bib123]), their access to CD4 molecules is augmented by the large numbers of HIV particles found within VCCs and the high frequency of serial DC:T cell interactions that occur in lymphoid organs. It is important to note that, although gp120-dependent signaling is initiated downstream of either the CD4 molecule or the CXCR4/CCR5 co-receptor, gp120:CD4 engagement is a requirement for both ([@bib68]). Lck phosphorylation occurs downstream of the CD4 molecule, whereas calcium signaling is exclusively downstream of chemokine receptors, but these signals converge to regulate T cell migration behavior and function. Prior engagement of gp120 by the CD4 molecule can induce a conformational change that supports subsequent binding with the co-receptor, indicating that CD4 and co-receptor do not have to be present at the same time ([@bib87]; [@bib116]). This raises an intriguing possibility that serial T cell scanning behaviors can "prime" virion-associated Env within VCCs, potentiating subsequent T cell encounters that induce a unique signaling cascade to modulate T cell motility, cell-cell adhesion, and HIV susceptibility.

In summary, we undertook a visualization-based approach using 3D collagen to better characterize the dynamics of DC-HIV capture, retention, and transmission of virus to susceptible T cells. We describe a mechanism by which surface-bound HIV particles on motile DCs function as adhesive receptors to contact and restrain migrating T cells to facilitate DC-to-T cell viral spread. Subsequent activation of signaling cascade facilitated by Env:CD4 binding further modulates T cell migration behaviors to enhance HIV susceptibility, providing additional insights into cellular mechanisms that contribute to the exponential viral replication observed in lymphoid organs during acute infection.

Limitations of the Study {#sec3.1}
------------------------

The present study examined DC:T cell interaction dynamics and activation of signaling pathways in the presence of HIV particles within a 3D collagen model to more closely recapitulate cell-cell contacts in lymph nodes. These studies are yet to be verified *in vivo* using multiphoton intravital microscopy (MP-IVM) ([@bib74]; [@bib76]; [@bib108]), where interactions with stromal and other immune lymph node cells in the presence of physiological blood and lymph flow can further modulate DC:T cell conjugate formations. The current study was also limited to monocyte-derived dendritic cells to model HIV-capture dynamics in collagen, and thus further validation using primary DC subsets isolated from mucosal tissues is warranted.
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